0 NASDAQ Companies - May 5, 2020Sify reports Revenues of INR 22952 Million for Financial Year 2019-20EBITDA for the year stood at INR 4076 MillionNet Profit for the year was INR 706 MillionCHENNAI, India, May 05, […]Read More
0 NASDAQ Companies - May 5, 2020XOMA Reports First Quarter 2020 Financial Results and Provides COVID-19 Business UpdateEMERYVILLE, Calif., May 05, 2020 (GLOBE NEWSWIRE) — XOMA Corporation (Nasdaq: XOMA) reported its first quarter 2020 financial results and […]Read More
0 NASDAQ Companies - May 5, 2020Ebix Hosts Q1 Investor Call Monday, May 11th at 11:00 a.m. ETJOHNS CREEK, Ga., May 05, 2020 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software […]Read More
0 NASDAQ Companies - May 5, 2020Rekor Launches New Visual IdentityCOLUMBIA, Md., May 05, 2020 (GLOBE NEWSWIRE) — Rekor (Nasdaq: REKR) (“the Company”), a Maryland-based company using AI to provide […]Read More
0 NASDAQ Companies - May 5, 2020Resonant Inc. to Participate in the Oppenheimer 5th Annual Emerging Growth ConferenceGOLETA, Calif., May 05, 2020 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, […]Read More
0 NASDAQ Companies - May 5, 2020Amicus Therapeutics Announces Upcoming Presentations at the American Society of Gene & Cell Therapy 23rd Annual MeetingCRANBURY, N.J., May 05, 2020 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) a global, patient-dedicated biotechnology company focused on discovering, […]Read More
0 NASDAQ Companies - May 5, 2020Karyopharm Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress— Pivotal Phase 3 BOSTON Study Meets Primary Endpoint with Significant Increase in Progression-Free Survival; Oral Presentation at ASCO 2020 […]Read More
0 NASDAQ Companies - May 5, 2020Cyclacel Pharmaceuticals to Release First Quarter 2020 Financial ResultsBERKELEY HEIGHTS, N.J., May 05, 2020 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), […]Read More
0 NASDAQ Companies - May 5, 2020Antares Pharma Reports First Quarter 2020 Operating and Financial ResultsFirst Quarter 2020 Revenue $33.1 Million, a 42% Increase Compared to First Quarter 2019Generated $5.6 Million in Cash from Operations […]Read More
0 NASDAQ Companies - May 5, 2020BioXcel Therapeutics to Host First Quarter 2020 Operating and Financial Results Conference Call and WebcastNEW HAVEN, Conn., May 05, 2020 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (“BTI” or “Company”) (Nasdaq: BTAI), a clinical-stage biopharmaceutical […]Read More